{"generic":"Erythromycin\/Benzoyl Peroxide","drugs":["Benzamycin Pak","Erythromycin\/Benzoyl Peroxide"],"mono":{"0":{"id":"211719-s-0","title":"Generic Names","mono":"Erythromycin\/Benzoyl Peroxide"},"1":{"id":"211719-s-1","title":"Dosing and Indications","sub":{"0":{"id":"211719-s-1-4","title":"Adult Dosing","mono":"<b>Acne vulgaris:<\/b> TOPICALLY twice daily "},"1":{"id":"211719-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and effectiveness have not been established for children under the age of 12 years<\/li><li><b>Acne vulgaris:<\/b> age 12 years and older, TOPICALLY twice daily<\/li><\/ul>"},"3":{"id":"211719-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><br\/>Acne vulgaris<br\/>"}}},"3":{"id":"211719-s-3","title":"Contraindications\/Warnings","sub":[{"id":"211719-s-3-9","title":"Contraindications","mono":"hypersensitivity to any component of the product <br\/>"},{"id":"211719-s-3-10","title":"Precautions","mono":"<ul><li>concomitant use of other topical acne agents<\/li><li>severe irritation may occur; discontinuation of therapy may be necessary<\/li><\/ul>"},{"id":"211719-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"211719-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: Compatible with breastfeeding.<\/li><li>Micromedex: Infant risk cannot be ruled out.<\/li><\/ul>"}]},"4":{"id":"211719-s-4","title":"Drug Interactions","sub":[{"id":"211719-s-4-13","title":"Contraindicated","mono":"<ul><li>Amifampridine (theoretical)<\/li><li>Astemizole (probable)<\/li><li>Bepridil (theoretical)<\/li><li>Cisapride (probable)<\/li><li>Colchicine (probable)<\/li><li>Dihydroergotamine (probable)<\/li><li>Dronedarone (theoretical)<\/li><li>Ergoloid Mesylates (probable)<\/li><li>Ergonovine (probable)<\/li><li>Ergotamine (probable)<\/li><li>Fluconazole (theoretical)<\/li><li>Grepafloxacin (probable)<\/li><li>Levomethadyl (probable)<\/li><li>Lomitapide (theoretical)<\/li><li>Lovastatin (probable)<\/li><li>Mesoridazine (established)<\/li><li>Methylergonovine (probable)<\/li><li>Methysergide (probable)<\/li><li>Pimozide (theoretical)<\/li><li>Piperaquine (theoretical)<\/li><li>Posaconazole (theoretical)<\/li><li>Saquinavir (theoretical)<\/li><li>Simvastatin (established)<\/li><li>Sparfloxacin (theoretical)<\/li><li>Terfenadine (theoretical)<\/li><li>Thioridazine (theoretical)<\/li><li>Ziprasidone (theoretical)<\/li><\/ul>"},{"id":"211719-s-4-14","title":"Major","mono":"<ul><li>Acecainide (theoretical)<\/li><li>Afatinib (theoretical)<\/li><li>Ajmaline (probable)<\/li><li>Amiodarone (theoretical)<\/li><li>Amisulpride (theoretical)<\/li><li>Amitriptyline (theoretical)<\/li><li>Amoxapine (theoretical)<\/li><li>Anagrelide (theoretical)<\/li><li>Apixaban (theoretical)<\/li><li>Apomorphine (theoretical)<\/li><li>Aprindine (theoretical)<\/li><li>Aripiprazole (theoretical)<\/li><li>Arsenic Trioxide (theoretical)<\/li><li>Asenapine (theoretical)<\/li><li>Atorvastatin (probable)<\/li><li>Azimilide (theoretical)<\/li><li>Azithromycin (theoretical)<\/li><li>Bedaquiline (theoretical)<\/li><li>Bosutinib (theoretical)<\/li><li>Bretylium (theoretical)<\/li><li>Buserelin (theoretical)<\/li><li>Carbamazepine (established)<\/li><li>Ceritinib (theoretical)<\/li><li>Cerivastatin (probable)<\/li><li>Chloral Hydrate (theoretical)<\/li><li>Chloroquine (theoretical)<\/li><li>Chlorpromazine (theoretical)<\/li><li>Cilostazol (theoretical)<\/li><li>Ciprofloxacin (theoretical)<\/li><li>Citalopram (theoretical)<\/li><li>Clarithromycin (theoretical)<\/li><li>Clindamycin (theoretical)<\/li><li>Clomipramine (theoretical)<\/li><li>Clozapine (theoretical)<\/li><li>Cobicistat (theoretical)<\/li><li>Crizotinib (theoretical)<\/li><li>Cyclobenzaprine (theoretical)<\/li><li>Dabigatran Etexilate (theoretical)<\/li><li>Dabrafenib (theoretical)<\/li><li>Daclatasvir (theoretical)<\/li><li>Darunavir (theoretical)<\/li><li>Dasabuvir (theoretical)<\/li><li>Dasatinib (theoretical)<\/li><li>Degarelix (theoretical)<\/li><li>Delamanid (theoretical)<\/li><li>Desipramine (theoretical)<\/li><li>Deslorelin (theoretical)<\/li><li>Dibenzepin (theoretical)<\/li><li>Digoxin (established)<\/li><li>Diltiazem (probable)<\/li><li>Disopyramide (probable)<\/li><li>Dofetilide (probable)<\/li><li>Dolasetron (probable)<\/li><li>Domperidone (theoretical)<\/li><li>Donepezil (probable)<\/li><li>Doxepin (theoretical)<\/li><li>Doxorubicin (theoretical)<\/li><li>Doxorubicin Hydrochloride Liposome (theoretical)<\/li><li>Droperidol (theoretical)<\/li><li>Eliglustat (theoretical)<\/li><li>Encainide (theoretical)<\/li><li>Enflurane (theoretical)<\/li><li>Eplerenone (probable)<\/li><li>Escitalopram (theoretical)<\/li><li>Eslicarbazepine Acetate (theoretical)<\/li><li>Everolimus (probable)<\/li><li>Fentanyl (theoretical)<\/li><li>Fingolimod (theoretical)<\/li><li>Flecainide (theoretical)<\/li><li>Fluoxetine (theoretical)<\/li><li>Formoterol (theoretical)<\/li><li>Foscarnet (theoretical)<\/li><li>Gatifloxacin (probable)<\/li><li>Gemifloxacin (probable)<\/li><li>Gonadorelin (theoretical)<\/li><li>Goserelin (theoretical)<\/li><li>Granisetron (theoretical)<\/li><li>Halofantrine (probable)<\/li><li>Haloperidol (theoretical)<\/li><li>Halothane (theoretical)<\/li><li>Histrelin (theoretical)<\/li><li>Hydrocodone (theoretical)<\/li><li>Hydroquinidine (probable)<\/li><li>Hydroxychloroquine (probable)<\/li><li>Ibrutinib (theoretical)<\/li><li>Ibutilide (theoretical)<\/li><li>Idelalisib (theoretical)<\/li><li>Ifosfamide (theoretical)<\/li><li>Iloperidone (theoretical)<\/li><li>Imipramine (theoretical)<\/li><li>Isoflurane (theoretical)<\/li><li>Isradipine (theoretical)<\/li><li>Itraconazole (probable)<\/li><li>Ivabradine (theoretical)<\/li><li>Ivacaftor (theoretical)<\/li><li>Ketoconazole (probable)<\/li><li>Lapatinib (theoretical)<\/li><li>Leuprolide (theoretical)<\/li><li>Levofloxacin (theoretical)<\/li><li>Lidoflazine (theoretical)<\/li><li>Lopinavir (theoretical)<\/li><li>Lorcainide (theoretical)<\/li><li>Lumefantrine (theoretical)<\/li><li>Lurasidone (probable)<\/li><li>Mefloquine (theoretical)<\/li><li>Metronidazole (theoretical)<\/li><li>Mifepristone (theoretical)<\/li><li>Mitotane (theoretical)<\/li><li>Morphine (theoretical)<\/li><li>Morphine Sulfate Liposome (theoretical)<\/li><li>Moxifloxacin (theoretical)<\/li><li>Nafarelin (theoretical)<\/li><li>Naloxegol (theoretical)<\/li><li>Nilotinib (theoretical)<\/li><li>Nintedanib (theoretical)<\/li><li>Norfloxacin (theoretical)<\/li><li>Nortriptyline (theoretical)<\/li><li>Octreotide (theoretical)<\/li><li>Ofloxacin (theoretical)<\/li><li>Olaparib (theoretical)<\/li><li>Ombitasvir (theoretical)<\/li><li>Ondansetron (theoretical)<\/li><li>Oxycodone (theoretical)<\/li><li>Paliperidone (theoretical)<\/li><li>Panobinostat (theoretical)<\/li><li>Paritaprevir (theoretical)<\/li><li>Pasireotide (theoretical)<\/li><li>Pazopanib (theoretical)<\/li><li>Pentamidine (theoretical)<\/li><li>Perflutren Lipid Microsphere (theoretical)<\/li><li>Pirmenol (probable)<\/li><li>Pitavastatin (probable)<\/li><li>Pixantrone (theoretical)<\/li><li>Pomalidomide (theoretical)<\/li><li>Prajmaline (probable)<\/li><li>Primidone (theoretical)<\/li><li>Probucol (theoretical)<\/li><li>Procainamide (probable)<\/li><li>Prochlorperazine (theoretical)<\/li><li>Promethazine (theoretical)<\/li><li>Propafenone (theoretical)<\/li><li>Protriptyline (theoretical)<\/li><li>Quetiapine (theoretical)<\/li><li>Quinidine (probable)<\/li><li>Quinine (probable)<\/li><li>Ranolazine (theoretical)<\/li><li>Risperidone (theoretical)<\/li><li>Romidepsin (theoretical)<\/li><li>Sematilide (theoretical)<\/li><li>Sertindole (theoretical)<\/li><li>Sevoflurane (theoretical)<\/li><li>Siltuximab (theoretical)<\/li><li>Simeprevir (established)<\/li><li>Sodium Phosphate (theoretical)<\/li><li>Sodium Phosphate, Dibasic (theoretical)<\/li><li>Sodium Phosphate, Monobasic (theoretical)<\/li><li>Solifenacin (theoretical)<\/li><li>Sorafenib (theoretical)<\/li><li>Sotalol (theoretical)<\/li><li>Spiramycin (theoretical)<\/li><li>Sulfamethoxazole (theoretical)<\/li><li>Sultopride (theoretical)<\/li><li>Sunitinib (theoretical)<\/li><li>Tacrolimus (probable)<\/li><li>Tadalafil (theoretical)<\/li><li>Tedisamil (theoretical)<\/li><li>Telaprevir (theoretical)<\/li><li>Telavancin (theoretical)<\/li><li>Telithromycin (theoretical)<\/li><li>Tetrabenazine (theoretical)<\/li><li>Theophylline (established)<\/li><li>Tizanidine (theoretical)<\/li><li>Tolvaptan (theoretical)<\/li><li>Topotecan (theoretical)<\/li><li>Toremifene (theoretical)<\/li><li>Trabectedin (theoretical)<\/li><li>Trazodone (theoretical)<\/li><li>Trifluoperazine (theoretical)<\/li><li>Trimethoprim (theoretical)<\/li><li>Trimipramine (theoretical)<\/li><li>Triptorelin (theoretical)<\/li><li>Troleandomycin (probable)<\/li><li>Vandetanib (theoretical)<\/li><li>Vardenafil (theoretical)<\/li><li>Vasopressin (theoretical)<\/li><li>Vemurafenib (theoretical)<\/li><li>Verapamil (probable)<\/li><li>Vilanterol (theoretical)<\/li><li>Vinblastine (probable)<\/li><li>Vincristine (theoretical)<\/li><li>Vincristine Sulfate Liposome (theoretical)<\/li><li>Vinflunine (theoretical)<\/li><li>Voriconazole (theoretical)<\/li><li>Warfarin (established)<\/li><li>Zolmitriptan (theoretical)<\/li><li>Zotepine (theoretical)<\/li><\/ul>"},{"id":"211719-s-4-15","title":"Moderate","mono":"<ul><li>Alfentanil (probable)<\/li><li>Alprazolam (probable)<\/li><li>Anisindione (probable)<\/li><li>Avanafil (probable)<\/li><li>Bexarotene (probable)<\/li><li>Bromocriptine (probable)<\/li><li>Budesonide (probable)<\/li><li>Buspirone (probable)<\/li><li>Cyclosporine (probable)<\/li><li>Diazepam (probable)<\/li><li>Dicumarol (probable)<\/li><li>Methylprednisolone (probable)<\/li><li>Midazolam (established)<\/li><li>Phenprocoumon (probable)<\/li><li>Roflumilast (established)<\/li><li>Salmeterol (established)<\/li><li>Sildenafil (probable)<\/li><li>Sirolimus (probable)<\/li><li>Tolterodine (probable)<\/li><li>Triazolam (probable)<\/li><li>Trimetrexate (probable)<\/li><li>Valproic Acid (probable)<\/li><li>Zafirlukast (probable)<\/li><\/ul>"}]},"5":{"id":"211719-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Application site reaction (0.8% to 2.5%), Dry skin (5% to 7.6%), Urticaria<br\/>"},"6":{"id":"211719-s-6","title":"Drug Name Info","sub":{"0":{"id":"211719-s-6-17","title":"US Trade Names","mono":"Benzamycin Pak<br\/>"},"2":{"id":"211719-s-6-19","title":"Class","mono":"<ul><li>Antiacne<\/li><li>Macrolide<\/li><\/ul>"},"3":{"id":"211719-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"211719-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"211719-s-9","title":"Administration","mono":"<ul><li><b>General Information<\/b><br\/>Not for ophthalmic use<br\/><\/li><li><b>Topical<\/b><br\/><ul><li>Benzamycin(R) topical gel: reconstitute prior to dispensing, tap vial until powder flows freely; add 6 mL of room temperature 70% ethyl alcohol to the mark on the vial and shake to dissolve completely; add contents of the vial to the gel and stir for 1 to 1.5 minutes to form a homogeneous mixture; refrigerate following reconstitution<\/li><li>Benzamycin(R) Pak: mix together the 2 compartments of one foil pouch in the palm of the hand immediately prior to use<\/li><li>wash, rinse, and pat the affected area dry prior to application.<\/li><li>avoid contact with eyes and mucous membranes<\/li><li>wash hands following application<\/li><li>may bleach hair or colored fabric<\/li><li>Benzamycin(R) topical gel: must be used within 3 months of mixing<\/li><\/ul><\/li><\/ul>"},"10":{"id":"211719-s-10","title":"Monitoring","mono":"improvement in signs and symptoms of acne vulgaris including a decrease in lesion count is indicative of efficacy<br\/>"},"11":{"id":"211719-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Gel\/Jelly: (Benzoyl Peroxide - Erythromycin) 5 %-3 %<br\/><\/li><li><b>Benzamycin Pak<\/b><br\/>Topical Gel\/Jelly: (Benzoyl Peroxide - Erythromycin) 5 %-3 %<br\/><\/li><li><b>Benzamycin<\/b><br\/>Topical Gel\/Jelly: (Benzoyl Peroxide - Erythromycin) 5 %-3 %<br\/><\/li><\/ul>"},"12":{"id":"211719-s-12","title":"Toxicology","sub":[{"id":"211719-s-12-31","title":"Clinical Effects","mono":"<ul><li><b>BENZOYL PEROXIDE<\/b><br\/>USES: Benzoyl peroxide is commonly utilized as a 2.5% to 10% topical preparation for treatment of inflammatory acne, decubital and stasis ulcers, and pyoderma gangrenosum. Benzoyl peroxide is used in industry as an oxidizing agent, a polymerization initiator, a catalyst, and a curing agent. Benzoyl peroxide is utilized as a source of free radicals in organic synthesis, and is used in dental resin cement, for automobile body putty, in roof bolting, and in the mining industry. PHARMACOLOGY: Benzoyl peroxide has antimicrobial activity. TOXICOLOGY: Benzoyl peroxide is irritating to skin and mucous membranes. Allergic dermatitis may occur. EPIDEMIOLOGY: Overdose is rare and clinically significant toxicity has not been reported. OVERDOSE: No overdoses resulting in significant toxicity have been reported. ADVERSE EFFECTS: Contact dermatitis, xeroderma, erythema, and skin peeling.<br\/><\/li><li><b>MACROLIDE ANTIBIOTICS <\/b><br\/>OVERDOSE: Significant toxicity following acute overdose is uncommon.  N\/V, abdominal pain may occur.  ADVERSE EFFECTS: N\/V, abdominal pain, diarrhea most common.  Cholestasis, sensorineural hearing loss, thrombophlebitis (IV administration), ventricular dysrhythmias\/QT prolongation (IV administration) are less common.<br\/><\/li><\/ul>"},{"id":"211719-s-12-32","title":"Treatment","mono":"<ul><li><b>BENZOYL PEROXIDE<\/b><br\/><ul><li>Support: MANAGEMENT OF MILD TO MODERATE TOXICITY: Treatment is symptomatic and supportive. MANAGEMENT OF SEVERE TOXICITY: Treatment is symptomatic and supportive. Significant toxicity is not expected after benzoyl peroxide overdose. INHALATION EXPOSURE: Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with inhaled beta-2 agonist and oral or parenteral corticosteroids. DERMAL EXPOSURE: Remove contaminated clothing and wash exposed area extremely thoroughly with soap and water. A physician may need to examine the area if irritation or pain persists after washing. EYE EXPOSURE: Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.<\/li><li>Decontamination: Gastrointestinal decontamination is not indicated. Wash exposed skin and irrigate exposed eyes.<\/li><li>Airway management: Airway compromise is not expected in isolated benzoyl peroxide ingestions.<\/li><li>Antidote: None<\/li><li>Enhanced elimination procedure: Not indicated.<\/li><li>Patient disposition: HOME CRITERIA: Asymptomatic patients and patients with isolated skin irritation and erythema can be managed at home with observation. OBSERVATION CRITERIA; Patients with severe skin symptoms and non-skin symptoms, and patients with deliberate overdoses should be referred to a health care facility for observation and treatment. ADMISSION CRITERIA: Patients are not expected to develop toxicity requiring admission. CONSULT CRITERIA:  Consult a poison center or medical toxicologist for assistance in managing patients with severe toxicity or in whom the diagnosis is not clear.<\/li><\/ul><\/li><li><b>MACROLIDE ANTIBIOTICS <\/b><br\/><ul><li>Decontamination: Activated charcoal, gastric lavage.<\/li><li>Support: Therapy as indicated.<\/li><li>Abdominal discomfort: Food, milk or an antacid  may be given; most effects reverse with drug cessation<\/li><li>Monitoring of patient: Baseline ECG, cardiac monitoring as indicated. Renal and hepatic function as indicated.<\/li><\/ul><\/li><\/ul>"},{"id":"211719-s-12-33","title":"Range of Toxicity","mono":"<ul><li><b>BENZOYL PEROXIDE<\/b><br\/>TOXICITY: Human exposure equal to or greater than 12.2 mg\/m(3) produces nose and throat irritation.<br\/><\/li><li><b>MACROLIDE ANTIBIOTICS<\/b><br\/>In general, the macrolide antibiotics are of a low order toxicity.<br\/><\/li><\/ul>"}]},"13":{"id":"211719-s-13","title":"Clinical Teaching","mono":"<ul><li>Drug causes sun-sensitivity. Patient should wear a hat or clothing to minimize sun exposure.<\/li><li>Drug may bleach hair or fabric.<\/li><li>Drug may cause dryness, urticaria, stinging, a burning sensation, tingling, or erythema.<\/li><li>Patient should avoid contact with mucous membranes (eyes, nose, or mouth).<\/li><li>Do not use with any other topical acne preparation without approval by physician.<\/li><li>Patient should not mix or apply near an open flame.<\/li><\/ul>"}}}